Funding Received
$5.1 Million in 2 Rounds from 5 Investors
Most Recent Funding
$3.3 Million Series B on May 13, 2014
Founded:
2007
Headquarters:
San Francisco, CA
Description:
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Founders:
Daryl Faulds
Categories:
Biotechnology
Website:
http://www.gemmuspharma.com

Detailed Description

Update

Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

Current Team (1)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    409 Illinois Street, Suite 4004

    San Francisco, CA 94158

    USA

Images (1)

Update
  • 87b1660bac5c8719fcbd70079369b8b3